Treatment of Forehead/Glabellar Rhytide Complex With Onabotulinum Toxin A Versus Incobotulinum Toxin A Injection: A Split-face, Double-blinded, Randomized Control Trial
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Skin wrinkles
- Focus Therapeutic Use
- 05 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2017.
- 05 Dec 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Dec 2017.
- 11 Feb 2016 Planned End Date changed from 1 Nov 2015 to 1 Nov 2016 as reported by ClinicalTrials.gov record.